Sign inJoin waitlistJoin the waitlist

Jona Hattangadi-Gluth

Physician · Proton Doctors Professional Corporation

Credentials: · · ·

History

Proton Doctors Professional Corporation
Present

Radiation Oncology
Mass General Brigham
2008–2012
Preliminary or Transitional Year
2007–2008
Harvard Medical School
2003–2007

Research

Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours
Review · Nature Reviews Neurology · 2017 · 422 citations
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2020 · 405 citations
Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline
Systematic review or meta-analysis · Practical Radiation Oncology · 2022 · 334 citations

Carrie McDonald
47 papers
Nikdokht Farid
31 papers
Tyler Seibert
30 papers · 21 as a resident
Kathryn Tringale
23 papers · 11 as a resident
Deborah Marshall
20 papers · 11 as a resident
Minh-Phuong Huynh-Le
19 papers · 14 as a resident
Mia Salans
18 papers · 11 as a resident
MC
Michael Connor
16 papers · 4 as a resident
David Piccioni
12 papers
Michelle Tibbs
12 papers · 8 as a resident
Daniel Simpson
10 papers · 4 as a resident
Alena Stasenko
9 papers

Grants

Mechanisms of Radiation-Induced Neurocognitive Decline (MIND): Longitudinal Study of Imaging Biomarkers and Risk and Resilience Factors Underlying Cognitive Phenotypes in Patients with Glioma
National Cancer Institute · R01
Contact PI · $1.3M · University of California, San Diego
2024–2029
Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases: Avoidance of Eloquent White Matter and Hippocampal Regions
National Cancer Institute · R01
Contact PI · $736.8K · University of California, San Diego
2019–2024

Clinical trials

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions
Principal investigator · Recruiting · Phase 2
Jona Hattangadi-Gluth
2019–2028
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
Site PI · Recruiting · Phase 2
RTOG Foundation, Inc.
2025–2030
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2033